Home - Products - Others - Other Targets - 1,2:5,6-Di-O-isopropylidene-alpha-D-ribo-hexofuranose

1,2:5,6-Di-O-isopropylidene-alpha-D-ribo-hexofuranose

CAS No. 2595-05-3

1,2:5,6-Di-O-isopropylidene-alpha-D-ribo-hexofuranose( —— )

Catalog No. M37897 CAS No. 2595-05-3

1,2:5,6-Di-O-isopropylidene-alpha-D-ribo-hexofuranose is a pharmaceutical intermediate used in liquid crystal materials.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 26 In Stock

Biological Information

  • Product Name
    1,2:5,6-Di-O-isopropylidene-alpha-D-ribo-hexofuranose
  • Note
    Research use only, not for human use.
  • Brief Description
    1,2:5,6-Di-O-isopropylidene-alpha-D-ribo-hexofuranose is a pharmaceutical intermediate used in liquid crystal materials.
  • Description
    1,2:5,6-Di-O-isopropylidene-alpha-D-ribo-hexofuranose is a pharmaceutical intermediate used in liquid crystal materials.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2595-05-3
  • Formula Weight
    260.28
  • Molecular Formula
    C12H20O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1(C)OC[C@@H](O1)[C@H]1O[C@@H]2OC(C)(C)O[C@@H]2[C@@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Acutumine

    (?)-Acutumine is a tetracyclic chloroalkaloid that exhibits selective cytotoxicity to cultured human T cells and memory-enhancing properties in the Wistar rat model.

  • AZD4747

    AZD4747 is a selective and potent inhibitor of the mutant GTPase KRASG12C that crosses the blood-brain barrier and has potential antitumor activity for the study of pancreatic and colorectal adenocarcinoma.

  • Milatuzumab

    Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74. Milatuzumab promotes the production of free radical oxygen and the loss of mitochondrial membrane potential, reduces CD20/CD74 aggregates and cell adhesion, and induces cell death.